MATTISSE Breast self-reconstruction: The Promise of Breast Reconstruction with patients’ own tissue
- Coordinator
- Lattice Medical, France
- Runs
- 1 October 2022 to 30 September 2024
- Status
- Running
- EU funding
- €2.4m
- Total cost
- €3.5m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190174063
What the project is doing
In the project's own words, from its summary on CORDIS.
LATTICE MEDICAL develops MATTISSE, a fully degradable 3D printed breast implant allowing a natural and custom breast reconstruction in a single and simple surgery. MATTISSE technology uses a Tissue Engineering Chamber implanted in the former breast and made of 3D printed biocompatible and bioabsorbable polymer. MATTISSE regenerates autologous adipose tissue within 3-6 months, women recover a full breast in 18 months with a fully degraded implant at an affordable price and free from numerous surgical procedures.
There is no longer any risk related to silicone implants thanks to the complete recovery with natural tissue. After validating the effectiveness of the MATTISSE medical device on animal models, this project aims at performing the mandatory clinical studies to launch the product on the EU market with the CE mark. A commercial team will be recruited to define and implement a marketing plan to ensure the success of MATTISSE.
Lattice Medical plans to support 40000 women by 2030.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Lattice Medical | Loos | France | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI